97761284 - KSQ

Information

  • Trademark
  • 97761284
  • Serial Number
    97761284
  • Filing Date
    January 19, 2023
    a year ago
  • Transaction Date
    October 01, 2024
    a month ago
  • Status Date
    October 01, 2024
    a month ago
  • Location Date
    October 01, 2024
    a month ago
  • First Use Anywhere Date
    October 02, 2017
    7 years ago
  • First Use In Commerce Date
    October 02, 2017
    7 years ago
  • Status Code
    661
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    GRYGIEL, JONATHAN
  • Attorney Docket Number
    K07132000400
    Attorney Name
    Christina M. Licursi, Esq.
    Law Office Assigned Location Code
    N20
  • Owners
Mark Drawing Code
3
Mark Identification
KSQ
Case File Statements
  • DM0000: The mark consists of the stylized letters "KSQ", where the "Q" appears as a circular arrow and each letter is divided in half vertically.
  • GS0051: Pharmaceuticals for use in the treatment of cancer and autoimmune disease containing small molecules; cells for medical use; pharmaceuticals for use in the treatment of cancer and autoimmune disease
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Small molecules for scientific and research use; cells for scientific and research use
  • GS0421: Medical and scientific research in the field of cell therapies, biotechnology, and drug development; providing medical and scientific research information; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields
Case File Event Statements
  • 2/9/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/23/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/10/2023 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/17/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/17/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/17/2023 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/17/2023 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/16/2024 - 10 months ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/16/2024 - 10 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/17/2024 - 10 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/29/2024 - 10 months ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/29/2024 - 10 months ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/29/2024 - 10 months ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/24/2024 - 7 months ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/24/2024 - 7 months ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/1/2024 - 4 months ago
    17 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/1/2024 - 4 months ago
    19 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/1/2024 - 4 months ago
    18 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/30/2024 - a month ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/30/2024 - a month ago
    20 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/1/2024 - a month ago
    22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/24/2024 - 7 months ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME